Search results
In a first, AstraZeneca admits its Covid vaccine can cause rare blood clots
The Independent via Yahoo News· 11 hours agoCovishield was developed by the British-...countries, including Britain and India. Some studies...
US opens COVID vaccine to little kids, shots begin next week
AOL· 18 hours agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
German ex-soldier admits spying for Russia as trial opens
AFP via Yahoo News· 1 day agoA German former soldier on Monday admitted he had spied for Russia at the start of his trial, saying...
Updated Alberta Covid-19 vaccine advice misrepresented online
AFP via Yahoo News· 7 days agoAlberta announced new Covid-19 vaccination guidelines, but social media posts and articles claiming...
Big Pharma's Blockbuster Creation Continues to Disappoint
Mercola· 6 days agoMessenger ribonucleic acid (mRNA) vaccines are being described as a "new era in vaccinology."1 Research is underway to develop mRNA shots for not only coronaviruses ...
A better COVID treatment for the immunocompromised? Researchers create a non-toxic potential...
Medical Xpress· 3 hours agoThe more widely used medication is Paxlovid, a drug whose antiviral component, nirmatrelvir, is...
Can nasal Neosporin fight COVID? Surprising new research suggests it works
Salon.com· 3 days agoEver since, the internet has been rife with health misinformation on ways to treat or protect...
COVID-19 Vaccine Uptake in Undocumented Latinx Patients
Journal of the American Medical Association· 4 days agoThis cross-sectional study examines COVID-19 infection status, vaccination uptake, and perceptions about the vaccine among Latinx patients presenting to the emergency department in California.
Q&A on Reducing COVID-19 Risk for Elderly, Immunocompromised - FactCheck.org
FactCheck.org· 7 days agoWhile the risks associated with COVID-19 generally have decreased over time due to prior exposure to the vaccines and the virus, some people remain at elevated risk, such ...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock...
St. Joseph News-Press· 5 hours agoSHELTON, CT / ACCESSWIRE / April 30, 2024 / NanoViricides, Inc. (NYSE Amer: NNVC ) (the "Company"),...